Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_assertion type Assertion NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_head.
- NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_assertion description "[Despite more rapid onset and higher rate of CR than in other molecular subgroups, CRD was inferior in CCND1 without CD20 myeloma, resembling outcomes in MAF/MAFB and proliferation entities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_provenance.
- NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_assertion evidence source_evidence_literature NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_provenance.
- NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_assertion SIO_000772 20124509 NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_provenance.
- NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_assertion wasDerivedFrom befree-20140225 NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_provenance.
- NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_assertion wasGeneratedBy ECO_0000203 NP596374.RA2OVmuMsO1x3YfMotCDS7nonBs3wCR0RAEkWPbltt6iQ130_provenance.